Therapeutic evaluation of gliclazide-MR on blood glucose excursion by self-monitoring of blood glucose in type 2 diabetic patients
- VernacularTitle:2型糖尿病患者应用自我血糖监测评估格列齐特缓释片减少血糖波动的研究
- Author:
Yaxiong SHI
;
Jingxiong ZHOU
;
Yongjia LI
;
Geng TAO
- Publication Type:Journal Article
- Keywords:
Gliclazide;
Diabetes mellitus;
type 2;
Blood glucose excursion;
Self-monitor blood glucose
- From:
Chinese Journal of Endocrinology and Metabolism
2008;24(2):145-146
- CountryChina
- Language:Chinese
-
Abstract:
A total of 123 type 2 diabetics was randomised into 3 groups to receive gliclazide-MR, gliclazide or glibenclamide treatments for 16 weeks.All the subjects took self-monitoring of blood glucose (SMBG) during the trial.The effect of therapy was similar in 3 groups.The subtraction value between maximum and minimum blood glucose, mean postprandial maximum blood glucose, postprandial 2 h blood glucose, postprandial 2 h serum insulin and hypoglycaemia events were lower in gliclazide-MR group than those in glibenclamide group (all P＜0.01).The data suggest that SMBG is an useful method to evaluate blood glucose excursion.
